PARTNERS CAPITAL INVESTMENT GROUP, LLP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARTNERS CAPITAL INVESTMENT GROUP, LLP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,441,859
-36.2%
454,8450.0%0.04%
-27.1%
Q2 2023$2,260,580
+390.7%
454,845
+387.8%
0.05%
+140.0%
Q1 2023$460,645
-21.5%
93,2480.0%0.02%
-28.6%
Q4 2022$586,530
-41.8%
93,2480.0%0.03%
-53.3%
Q3 2022$1,007,000
-5.3%
93,2480.0%0.06%
-16.7%
Q2 2022$1,063,000
+25.2%
93,2480.0%0.07%
+71.4%
Q1 2022$849,000
-39.0%
93,2480.0%0.04%
-34.4%
Q4 2021$1,391,000
-41.9%
93,2480.0%0.06%
-41.8%
Q3 2021$2,396,000
-1.5%
93,2480.0%0.11%
+1.9%
Q2 2021$2,432,000
-34.9%
93,248
-11.8%
0.11%
-34.1%
Q1 2021$3,733,000
+13.1%
105,754
-19.1%
0.16%
-13.2%
Q4 2020$3,301,000
-36.1%
130,766
-4.6%
0.19%
-40.6%
Q3 2020$5,167,000
-18.8%
137,019
-7.8%
0.32%
+1.3%
Q2 2020$6,366,000
+96.1%
148,664
-11.0%
0.31%
+41.4%
Q1 2020$3,246,000
-32.0%
166,990
-9.1%
0.22%
-38.5%
Q4 2019$4,774,000183,7500.36%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders